These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31170120)

  • 1. Prucalopride (Motegrity) for chronic idiopathic constipation.
    Med Lett Drugs Ther; 2019 Jun; 61(1573):86-88. PubMed ID: 31170120
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanded table: some drugs for chronic idiopathic constipation.
    Med Lett Drugs Ther; 2019 Jun; 61(1573):e88-e90. PubMed ID: 31170121
    [No Abstract]   [Full Text] [Related]  

  • 3. Vibrant - an oral vibrating capsule for chronic idiopathic constipation.
    Med Lett Drugs Ther; 2023 May; 65(1675):65-67. PubMed ID: 37155248
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of prucalopride in adults with chronic idiopathic constipation.
    Vijayvargiya P; Camilleri M
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
    [No Abstract]   [Full Text] [Related]  

  • 5. Prucalopride: A Review in Chronic Idiopathic Constipation.
    Garnock-Jones KP
    Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prucalopride: a review of its use in the management of chronic constipation.
    Keating GM
    Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. prucalopride (Resolor°) and chronic constipation in men: Avoid in both men and women.
    Prescrire Int; 2016 Oct; 25(175):234. PubMed ID: 30645825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].
    Layer P; Dathe K; Dignass A; Faiss S; Galle P; Lerch MM; Malfertheiner P; Wehrmann T; Zeuzem S
    Z Gastroenterol; 2011 Aug; 49(8):969-70. PubMed ID: 21796580
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral prucalopride in children with functional constipation.
    Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M; Kerstens R; Rykx A; Vandeplassche L
    N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.
    Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B
    Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prucalopride succinate for the treatment of constipation: an update.
    Bassotti G; Gambaccini D; Bellini M
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the efficacy and safety of prucalopride for the treatment of chronic idiopathic constipation.
    Daniali M; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2019 Dec; 20(17):2073-2080. PubMed ID: 31557072
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for Irritable Bowel Syndrome.
    Med Lett Drugs Ther; 2020 Mar; 62(1594):25-32. PubMed ID: 32324172
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of prucalopride in adults and children with chronic constipation.
    Diederen K; Mugie SM; Benninga MA
    Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R; Chera D; Gruss HJ; Halphen M
    Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenapanor (Ibsrela) for irritable bowel syndrome with constipation.
    Med Lett Drugs Ther; 2022 Jun; 64(1652):91-94. PubMed ID: 35657365
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
    Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
    Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
    Tack J; Corsetti M
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In brief: Tegaserod (Zelnorm) returns.
    Med Lett Drugs Ther; 2019 May; 61(1571):72. PubMed ID: 31169806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.